Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Diacylglycerol (16:0/16:0) (Model 1)

MSRA · rs2952205

Strength of the evidence

2 / 4

Its strongest genetic-study result is p = 10−28, with 7 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 6,817 European ancestry individuals.

The effect Each copy of the A allele shifted the measure 0.159 higher; p = 1 × 10−19.

Where it sits Chromosome 8, band 8p23.1 — in an intron of MSRA.

How common each version is

AG
Korean KRGDB
A 50.2% · G 49.8%
Korean Korea4K
A 48.6% · G 51.4%
Korean Korea1K
A 49.0% · G 51.0%
Japanese ToMMo
A 50.2% · G 49.8%
Vietnamese
A 53.7% · G 46.3%
World gnomAD
A 58.7% · G 41.3%
World 1000 Genomes
A 58.3% · G 41.7%
World TOPMed
A 58.9% · G 41.1%

By ancestry gnomAD

East Asian
A 49.0% · G 51.0%
European (non-Finnish)
A 58.8% · G 41.2%
African / African American
A 66.8% · G 33.2%
South Asian
A 57.9% · G 42.1%
Admixed American (Latino)
A 47.4% · G 52.6%
Middle Eastern
A 63.4% · G 36.6%
Finnish
A 46.1% · G 53.9%
Ashkenazi Jewish
A 63.3% · G 36.6%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

A/A Two copies of the version the research linked to Diacylglycerol (16:0/16:0) (Model 1). That is the strongest link of the three results. A link in a study is not a diagnosis.
A/G One copy of the version the research linked to Diacylglycerol (16:0/16:0) (Model 1). That is a smaller link than two copies.
G/G No copy of the version the research linked to Diacylglycerol (16:0/16:0) (Model 1). This is the starting point the study compared everyone against.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Diacylglycerol (16:0/16:0) (Model 1) (rs2952205). MyGeneLog™. https://www.mygenelog.com/variants/rs2952205

← See all variants